ANVISA Adopts Certara’s Phoenix Software for Drug Regulatory Reviews

Published on: 

Applied Clinical Trials

Certara announced that the Brazilian National Health Surveillance Agency, ANVISA is now also employing Certara’s Phoenix WinNonlin software for reviewing drug regulatory submissions. With the adoption of Certara's software, reviewed studies will be evauated to see if they follow good bioequivalence practices.

Read the full release here